Phacilitate Leaders World


Robert  Piperno

Robert Piperno

QA Director, Cell & Gene Therapies, GlaxoSmithKline

Rob Piperno is Director QA, Cell and Gene Therapies at GSK.  In this role he is responsible for the building GSK’s quality systems to support the supply of GSK’s Cell and Gene Therapy products from clinical trials though to commercialization.  Prior to joining GSK R&D in 2012, Rob worked in the GSK corporate audit group supporting internal biopharmaceutical and vaccine sites.  Prior to joining GSK in 2009, Rob held numerous roles within the Johnson and Johnson biopharmaceutical QA organization.  He holds a Master degree in Biology from Rutgers University and a MBA in Pharmaceutical Marketing from St. Joseph’s University

  • Real thinking forward combining experts in the field from manufacturing, regulatory and value vision” – “great network with strong experience and sharing risks & opportunities
    Anne-Virginie Eggimann
    bluebird bio
  • Great program, great people, great venue.
    Klaus Kühlcke
  • Dynamic, interesting and highly interactive event that promotes exchange and networking in highly specialized field of gene therapy.
    Nathalie Clement
    Powell Gene Therapy Center, University of Florida
  • Phacilitate provides a unique forum, bringing together research, process development, and commercial leaders on the cutting edge of cell, gene, and immunotherapy. A great conference for anyone wanting a comprehensive view of the field.
    Dr James Trager
  • It was all business. I’ve never been to an event where over 80% of the conversations I had were constructive to my business objectives.
    Kurt Gielen
    Chemelot Campus B.V.
  • Great way to expand network with global experts in cell and gene therapy who are facing similar challenges.
    Steven Goodman